AAON vs ECG

AAON's Piotroski F-Score of 3/9 indicates weak financial health, signaling distress in operational efficiency and profitability trends. The company trades at a high forward P/E of 28.33 despite a recent 68.6% year-over-year earnings decline, suggesting overvaluation relative to current profitability. While the Graham Number ($17.83) and intrinsic value ($9.03) imply significant downside, the current price of $83.90 reflects strong growth expectations not yet supported by fundamentals. Insider selling totaling $3.19M in the last six months further undermines confidence, and the technical trend is bearish. The Altman Z-Score is unavailable, but the low Piotroski score raises red flags for financial stability.

ECG exhibits a stable financial foundation with a Piotroski F-Score of 6/9 and impressive growth metrics, including 60.2% YoY earnings growth. However, the stock is significantly overvalued, trading at $136.06—well above its Graham Number ($33.13) and Intrinsic Value ($116.53). While profitability is strong with an ROE of 38.34%, the technical trend is heavily bearish (10/100), suggesting the recent 232% one-year rally may have peaked. The valuation premium is high, and the current price exceeds the analyst target of $131.50.